Quoin Pharmaceuticals Ltd. Adjustments For Increase Decrease In Trade And Other Payables
Quoin Pharmaceuticals Ltd. (QNRX) reported Adjustments For Increase Decrease In Trade And Other Payables of ILS 1.40 million for the 6-month period ending 2021-06-30, per its 6-K filed 2021-08-24.
Discontinued › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables · last filed 2021-08-24
ILS
| Period end | Adjustments For Increase Decrease In Trade And Other Payables 6 month | Adjustments For Increase Decrease In Trade And Other Payables 12 month |
|---|---|---|
| 2021-06-30 | 1.40M ILS 6-K · filed 2021-08-24 | |
| 2020-12-31 | 2.72M ILS 20-F · filed 2021-03-29 | |
| 2020-06-30 | 3.81M ILS 6-K · filed 2021-08-24 | |
| 2019-12-31 | -8.64M ILS 20-F · filed 2021-03-29 | |
| 2019-06-30 | -8.44M ILS 6-K/A · filed 2021-02-11 | |
| 2018-12-31 | -7.72M ILS 20-F · filed 2021-03-29 | |
| 2018-06-30 | -1.89M ILS 6-K · filed 2019-08-13 | |
| 2017-12-31 | 3.00M ILS 20-F · filed 2020-04-03 | |
| 2017-06-30 | 5.31M ILS 6-K · filed 2018-08-09 | |
| 2016-12-31 | -1.24M ILS 20-F · filed 2019-03-18 |
USD
| Period end | Adjustments For Increase Decrease In Trade And Other Payables 6 month | Adjustments For Increase Decrease In Trade And Other Payables 12 month |
|---|---|---|
| 2021-06-30 | $430.00K 6-K · filed 2021-08-24 | |
| 2020-12-31 | $847.00K 20-F · filed 2021-03-29 | |
| 2019-12-31 | -$2.50M 20-F · filed 2020-04-03 | |
| 2018-06-30 | -$517.00K 6-K · filed 2018-08-09 | |
| 2017-12-31 | $866.00K 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |